{"SPADE_UN_16996": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16996", "Peptide Name": "[Lys(Ac)]2cyO2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GIPCGESCVWIPCISSAIGCSCXSXVCYRN", "Sequence Length": 30, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:U-937/GTB (IC50=2.3(2.0-2.5)μM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C121H187N33O36S6", "Mass": 360983, "PI": 5.94, "Net Charge": 0, "Hydrophobicity": 0.703, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2", "Pubmed ID": "16389447", "Reference": "Cell Mol Life Sci. 2006 Jan;63(2)235-45.", "Author": "Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16389447"}, {"Title": "The anthelmintic activity of the cyclotides: natural variants with enhanced activity", "Pubmed ID": "", "Author": "Colgrave ML, Kotze AC, Ireland DC, Wang CK, Craik DJ"}], "Frequent Amino Acids": "CSI", "Absent Amino Acids": "DFHKLMOQTU", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 11, "Polar Residues": 17, "Positive Residues": 1, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00750", "Similarity": 0.9642857142857143, "Sequence": "GIPCGESCVWIPCISSAIGCSCKSKVCYRN"}, {"SPADE_ID": "SPADE_N_00752", "Similarity": 0.9642857142857143, "Sequence": "GIPCGESCVWIPCISSAIGCSCKNKVCYRN"}, {"SPADE_ID": "SPADE_UN_17034", "Similarity": 0.9629629629629629, "Sequence": "GIPCGSCVWIPCISSAIGCSCKSKVCYRN"}]}}}